Literature DB >> 12234961

Overexpression of soluble fas attenuates transplant arteriosclerosis in rat aortic allografts.

Tao Wang1, Chunming Dong, Susan C Stevenson, Edward E Herderick, Jennifer Marshall-Neff, Sanjay S Vasudevan, Nicanor I Moldovan, Robert E Michler, N Rao Movva, Pascal J Goldschmidt-Clermont.   

Abstract

BACKGROUND: The killing of vascular cells by activated macrophages is an important step in the process of destabilization of the arterial wall. The death receptor Fas is implicated in vascular cell death. Hence, we extended our studies in a rat aortic allograft model, using adenovirus-mediated overexpression of soluble Fas (sFas) to block Fas binding to Fas ligand (Fas-L). The contribution of Fas to vascular cell injury and consequent transplant arteriosclerosis was investigated. METHODS AND
RESULTS: Activated monocytes in the presence of macrophage colony-stimulating factor induce endothelial cell apoptosis in vitro, which was significantly inhibited by adenovirus-mediated sFas overexpression. Next, donor rat abdominal aortas were either untreated or transduced with adenoviruses encoding (1) rat soluble Fas (Ad3rsFas), (2) no insert (Ad3Null), and (3) beta-galactosidase (Ad3nBg). A total of 175 aortic grafts were harvested 2 to 90 days after transplantation. Vascular cell apoptosis and CD45+ cell infiltration were significantly reduced in Ad3rsFas-transduced aortas, as compared with control allografts. Moreover, the control allografts developed marked intimal thickening, whereas Ad3rsFas-transduced allografts had significantly less neointima until the 90-day time point.
CONCLUSIONS: sFas overexpression protects the integrity of the vessel wall from immune injury and attenuates transplant arteriosclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234961     DOI: 10.1161/01.cir.0000027822.23269.07

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Adenovirus-mediated overexpression of glutathione-s-transferase mitigates transplant arteriosclerosis in rabbit carotid allografts.

Authors:  Ya Xu; Bin Gong; Yongzhen Yang; Yogesh C Awasthi; Paul J Boor
Journal:  Transplantation       Date:  2010-02-27       Impact factor: 4.939

2.  Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1.

Authors:  Jianli Niu; Asim Azfer; Michael F Deucher; Pascal J Goldschmidt-Clermont; Pappachan E Kolattukudy
Journal:  J Mol Cell Cardiol       Date:  2006-05-05       Impact factor: 5.000

3.  Increased serum concentrations of soluble CD95/Fas and caspase 1/ICE in patients with acute angina.

Authors:  H J Ankersmit; T Weber; J Auer; G Roth; M Brunner; E Kvas; B Moser; S Spreitzer; E Lassnig; E Maurer; P Hartl; E Wolner; G Boltz-Nitulescu; B Eber
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

4.  Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts.

Authors:  Jonathan C Choy; Alexandra Kerjner; Brian W Wong; Bruce M McManus; David J Granville
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

5.  Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis.

Authors:  Kinga Musiał; Danuta Zwolińska
Journal:  Apoptosis       Date:  2011-07       Impact factor: 4.677

Review 6.  FAS-670A>G gene polymorphism and the risk of allograft rejection after organ transplantation: a systematic review and meta-analysis.

Authors:  Mohammad Masoud Eslami; Ramazan Rezaei; Sara Abdollahi; Afshin Davari; Mohammad Ahmadvand
Journal:  Blood Res       Date:  2021-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.